We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+27.78%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$14.9M
Cap. Flow
-$11.9M
Cap. Flow %
-11.37%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
5
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$11.3M
2
TLPH icon
Talphera
TLPH
+$249K
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$145K
4
XNCR icon
Xencor
XNCR
+$101K
5
OREX
Orexigen Therapeutics, Inc.
OREX
+$80.5K

Sector Composition

Rank Sector Weight
1 Healthcare 69.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
1
Karyopharm Therapeutics
KPTI
$216M
$37.6M 36.04%
71,808
-20,019
-22% -$11.3M
AMBI
2
DELISTED
Ambit Biosciences Corp
AMBI
$32M 30.67%
2,079,569
– –
BDSI
3
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$11.8M 11.29%
690,000
-10,000
-1% -$145K
XNCR icon
4
Xencor
XNCR
$1.3B
$7.52M 7.2%
807,356
-9,944
-1% -$101K
OREX
5
DELISTED
Orexigen Therapeutics, Inc.
OREX
$5.26M 5.04%
123,500
-1,500
-1% -$80.5K
TLPH icon
6
Talphera
TLPH
$68.5M
$4.48M 4.29%
40,813
-1,586
-4% -$249K
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
$4.03M 3.86%
500,000
– –
XLRN
8
DELISTED
Acceleron Pharma
XLRN
$1.69M 1.61%
55,767
– –

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q3 2014 Portfolio in Review

As of Q3 2014, Foresite Capital Management I held 8 positions worth $104M, down 12% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management I withdrew a net $11.9M in Q3 2014, reducing 5 holdings. Its largest reduction was Karyopharm Therapeutics, cutting an estimated $11.3M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 88% a quarter earlier.

  • Foresite Capital Management I's biggest Q3 2014 reduction was Karyopharm Therapeutics, cutting an estimated $11.3M.
  • Foresite Capital Management I's ten largest holdings make up 100% of its $104M portfolio in Q3 2014.
  • Foresite Capital Management I opened 0 new positions and closed 0 in Q3 2014.
  • Foresite Capital Management I's portfolio value fell 12% quarter-over-quarter to $104M.

Based on Foresite Capital Management I's 13F filing for Q3 2014, filed 10 Nov 2014.